Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine intermittent bolus versus continuous infusion after VATS thoracic surgery
ACTRN12618001626257Phase 4Terminated
- Sponsor
- Austin Hospital
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ropivacaine in postoperative pain, sponsored by Austin Hospital. Primary endpoint: Oxycodone consumption on postoperative day 1. Started Feb 2019; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12618001626257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001626257.